NRXPNRx Pharmaceuticals, Inc.
3.560USD+6.91%Mkt Cap: 154.13M $P/E: —3d ago
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), an…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap154.13M $
Enterprise Value112.58M $
Revenue (TTM)2.29M $
Gross Profit720.00K $
Net Income (TTM)-28.62M $
Revenue/Share0.0900 USD
Last Price3.560 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6294441000
Valuation
P/E (Trailing)—
P/E (Forward)7.02
PEG—
EV/EBITDA-6.60
EV/Revenue49.10
P/S66.27
P/B-6.98
EPS (TTM)-0.53
EPS (Forward)0.50
52W Range
1.62056% of range5.055
52W High5.055 USD
52W Low1.620 USD
Profitability
Gross Margin58.78%
Oper. Margin-444.57%
EBITDA Margin0.00%
Profit Margin-2336.49%
ROE179.59%
ROA-220.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.11M $
CapEx (TTM)—
FCF Margin-372.53%
FCF Yield-5.54%
Net Debt-5.78M $
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity-0.04
Current Ratio0.29
Quick Ratio0.27
Book Value/Sh-0.5030 USD
Cash/Share0.1850 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 2, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)38.25 USD
Upside (mean)+974.4%
Target Range10.00 USD – 49.00 USD
$10.00+974.4% to mean$49.00
# Analysts4
Ownership
Shares Out.43.30M
Float31.23M
Insiders7.58%
Institutions32.42%
Short Interest
Short Ratio7.6d
Short % Float15.97%
Short % Out.15.31%
Shares Short6.55M
Short (prev mo.)5.40M
Technical
SMA 503.754 (-5.2%)
SMA 2002.796 (+27.3%)
Beta2.18
S&P 52W Chg18.16%
Avg Vol (30d)1.08M
Avg Vol (10d)1.58M
Technical Indicators
RSI (14)50.9
MACD-0.1171
MACD Signal-0.1522
MACD Hist.+0.0351
BB Upper3.905 USD
BB Middle3.379 USD
BB Lower2.854 USD
BB Width31.10%
ATR (14)0.3447 USD
Vol Ratio (20d)0.49x